Cytochrome p450 2C inhibition reduces post-ischemic vascular dysfunction (Q46693356)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Cytochrome p450 2C inhibition reduces post-ischemic vascular dysfunction	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16150654

Cytochrome p450 2C inhibition reduces post-ischemic vascular dysfunction (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16150654

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16150654

author name string

Arwen L Hunter

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16150654

Ni Bai

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16150654

David J Granville

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16150654

publication date

8 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16150654

Vascular Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16150654

43

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16150654

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16150654

213-219

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16150654

Cytochrome p-450 epoxygenase products contribute to attenuated vasoconstriction after chronic hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Cytochrome P450 epoxygenases and vascular tone: novel role for HMG-CoA reductase inhibitors in the regulation of CYP 2C expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Cytochrome p450 enzymes and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Selectivities of human cytochrome P450 inhibitors toward rat P450 isoforms: study with cDNA-expressed systems of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Plasma phospholipase A2 activity in clinical acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Endothelial and myogenic regulation of coronary artery tone in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Attenuation of ischemia and reperfusion injury of canine livers by inhibition of type II phospholipase A2 with LY329722.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: role of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Profound inhibition of myogenic tone in rat cardiac allografts is due to eNOS- and iNOS-based nitric oxide and an intrinsic defect in vascular smooth muscle contraction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

The effect of chronic treatment with trandolapril on cyclic AMP-and cyclic GMP-dependent relaxations in aortic segments of rats with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Accumulation of arachidonic acid in ischemic/reperfused cardiac tissue: possible causes and consequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Effect of CYP1A1 MspI polymorphism on cigarette smoking related coronary artery disease and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Gender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca(2+)-dependent K+ channels

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Inhibition of mitochondrial calcium-independent phospholipase A2 (iPLA2) attenuates mitochondrial phospholipid loss and is cardioprotective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of cardiac cytochrome p450 in cocaine-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.07.005

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VPH.2005.07.005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16150654

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16150654

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46693356&oldid=2126898833"